Feature

ASH urges lawmakers to keep opioids accessible


 

Finding balance

ASH leaders recognize the longstanding, complex nature of the opioid epidemic and want to be a part of the conversation to ensure their patients’ needs and considerations are met in future legislation, Dr. Alvarnas noted.

Dr. Meier, who is vice chair for public policy at Icahn School of Medicine at Mount Sinai, New York, said the issue of balance is paramount when considering good policymaking.

“No policy at either extreme is the right policy,” Dr. Meier said. “Good policymaking, good public health interventions attempt to achieve some balance ... in preventing harm and maximizing appropriate treatment of vulnerable, seriously ill patients. And the policies we have now don’t achieve that.”

The “Statement on Opioid Use in Patients with Hematologic Diseases and Disorders” is available on the ASH website.

Dr. Alvarnas is chair of the society’s Committee on Practice. Dr. Meier and Dr. Osunkwo reported having no relevant financial disclosures.

Pages

Recommended Reading

Drugmakers blamed for blocking generics have cost U.S. billions
MDedge Hematology and Oncology
Congress passes ‘right to try’ legislation
MDedge Hematology and Oncology
CMS proposes inpatient payment model for CAR T therapies
MDedge Hematology and Oncology
MDedge Daily News: Keeping patients summer safe
MDedge Hematology and Oncology
Peer mentorship, groups help combat burnout in female physicians
MDedge Hematology and Oncology
Geriatric assessments enhance patient care in advanced cancer
MDedge Hematology and Oncology
Metastatic colorectal cancer chemo costs double in Washington vs. British Columbia
MDedge Hematology and Oncology
Looking for lower Medicare drug costs? Ask your pharmacist for the cash price
MDedge Hematology and Oncology
AMA: Opioid prescriptions down since 2013
MDedge Hematology and Oncology
Verma unveils Medicaid scorecard but refuses to judge efforts
MDedge Hematology and Oncology